Delivery Order 36C24823D0050-36C24825N0092

Award Date 10/1/24
Potential Completion Date 9/30/25
Potential Value $930K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Norcross, GA, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, by the Department of Veterans Affairs (VA). The contract has a ceiling value of $108,619.89 and is a delivery order under a larger Indefinite Delivery Contract (IDC) or Blanket Purchase Agreement (BPA) vehicle. The contract is for the supply of radiopharmaceuticals and nuclear medicine products to support the VA's healthcare services for veterans, including gallium-based...
This federal contract award was issued by the Veterans Integrated Service Network 4 (VISN 4), a component of the U.S. Department of Veterans Affairs (VA), to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The $148,434.08 firm fixed-price purchase order is for the provision of radiopharmaceuticals, including Ga-68 Dotatate, gallium-based diagnostic imaging agents, iodine I-123, and various therapeutic radioisotopes. This contract supports the VA's medical...
This federal contract, valued at $439,477.00, was awarded to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit organization and self-certified small disadvantaged business. The contract, awarded by the Department of Veterans Affairs (VA) through its Veterans Integrated Service Network (VISN) 15, is for the supply of radiopharmaceuticals, including medical isotopes, diagnostic imaging agents, and therapeutic radioisotopes, to support nuclear medicine...
This federal contract award to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) is for the supply of nuclear medicine imaging radio-therapeutic isotopes to the Department of Veterans Affairs (VA). The $843,077.64 firm-fixed-price delivery order contract has a performance period extending through February 28, 2026. Jubilant Radiopharma, a for-profit small disadvantaged business, specializes in manufacturing, distributing, and supplying radiopharmaceuticals and...
This federal contract award, valued at $184,507.80, was issued by the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The contract is for the delivery of radiopharmaceuticals, which are specialized medical isotopes and imaging agents used in nuclear medicine procedures to support diagnostic imaging and cancer treatment services for veterans. Jubilant Radiopharma is a for-profit, self-certified small disadvantaged...
The Department of Veterans Affairs (VA) awarded a firm-fixed-price delivery order contract to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the supply of radiopharmaceuticals. The $740,177.94 contract is part of a larger $39.8 million multiple-award Indefinite Delivery Contract (IDC) with the VA's Network Contracting Office 8, as well as additional IDVs with the VA and Defense Health Agency (DHA) worth up...
This federal contract award, valued at $456,032.74, was issued by the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, on October 1, 2024. The contract is a firm-fixed-price delivery order under an Indefinite Delivery Contract (IDC) or Blanket Purchase Agreement (BPA) with the VA, with a performance period through September 30, 2025. Jubilant Radiopharma, a for-profit organization and self-certified small...
This federal contract award to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, is a $478,318.97 firm fixed-price purchase order issued by the Department of Veterans Affairs (VA) for the provision of radiopharmaceutical products and services. The contract has an ultimate completion date of April 30, 2025 and is not set aside for any particular business type. Jubilant Radiopharma is a self-certified small disadvantaged business that specializes in supplying...
This federal contract award, valued at $83,454.67, was issued by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a self-certified small disadvantaged business. The contract is for the delivery of radiopharmaceuticals, which are specialized nuclear medicine products used in diagnostic imaging and treatment procedures for veterans and military personnel. The contract is a delivery order under a larger Indefinite...
This contract award is for the supply of nuclear medicine radiopharmaceuticals to the Department of Veterans Affairs (VA). The prime contractor is Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. This award has a ceiling value of $73,037 and is a firm-fixed-price delivery order contract. Jubilant Radiopharma provides a variety of essential medical isotopes and radiopharmaceuticals used in diagnostic imaging and cancer...
  • 36C24823D0050
    Indefinite Delivery Contract
  • 36C24823D0050-36C24825N0092
    Delivery Order

This federal contract award is for RADIOPHARMACEUTICALS, awarded to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The contract, valued at $929,720.00, was awarded on October 1, 2024 by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 8 (VISN 8).

Jubilant Radiopharma is a key supplier of radiopharmaceuticals and nuclear medicine products to the VA, supporting its healthcare services for veterans across the country. The contract covers the supply of various radiopharmaceuticals, including Ga-68 Dotatate, gallium-based diagnostic imaging agents, iodine I-123, and therapeutic radioisotopes used in nuclear medicine procedures such as PET scans, cardiac imaging, and cancer treatment.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) or Blanket Purchase Agreement (BPA) held by Jubilant Radiopharma with the VA. These IDVs, ranging from $420,000 to $39.8 million in value, enable the VA to efficiently procure radiopharmaceuticals and related services across its nationwide network of medical facilities. The contract does not have a set-aside designation.

Generated 10/2/24, 10:06 AM